Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rotrosen

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Psychopharmacology Bulletin|January 1, 1989
GM1 ganglioside as a potential treatment in tardive dyskinesiaE D Peselow, S Irons, J Rotrosen, et al.
Alcoholism, Clinical and Experimental Research|February 1, 1987
Essential fatty acid supplementation during early alcohol abstinenceA Wolkin, D Segarnick, J Sierkierski, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1986
A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisiaL Adler, B Angrist, E Peselow, et al.
Nephron|January 1, 1987
Olfaction and hemodialysis: baseline and acute treatment decrementsP Conrad, J Corwin, L Katz, et al.
Archives of General Psychiatry|September 1, 1980
Prostaglandins, platelets, and schizophreniaJ Rotrosen, A D Miller, D Mandio, et al.
Biological Psychiatry|March 15, 1990
Basal ganglia calcification in schizophreniaA Fernandez-Bouzas, B Angrist, P Hemdal, et al.
Psychiatry Research|January 1, 1989
Effects of a specific beta 2-receptor blocker in neuroleptic-induced akathisiaL Adler, E Duncan, B Angrist, et al.
Neurobiology of Aging|January 1, 1984
CSF somatostatin in Alzheimer's diseaseM Serby, S B Richardson, S Twente, et al.
Psychopharmacology|December 21, 1976
Dopamine receptor alteration in schizophrenia: neuroendocrine evidenceJ Rotrosen, B M Angrist, S Gershon, et al.
Psychopharmacology Bulletin|January 1, 1989
Akathisia: selective beta-blockers and rating instrumentsL A Adler, E Duncan, A Kim, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Psychopharmacology Bulletin|January 1, 1989
GM1 ganglioside as a potential treatment in tardive dyskinesiaE D Peselow, S Irons, J Rotrosen, et al.
Alcoholism, Clinical and Experimental Research|February 1, 1987
Essential fatty acid supplementation during early alcohol abstinenceA Wolkin, D Segarnick, J Sierkierski, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1986
A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisiaL Adler, B Angrist, E Peselow, et al.
Nephron|January 1, 1987
Olfaction and hemodialysis: baseline and acute treatment decrementsP Conrad, J Corwin, L Katz, et al.
Archives of General Psychiatry|September 1, 1980
Prostaglandins, platelets, and schizophreniaJ Rotrosen, A D Miller, D Mandio, et al.
Biological Psychiatry|March 15, 1990
Basal ganglia calcification in schizophreniaA Fernandez-Bouzas, B Angrist, P Hemdal, et al.
Psychiatry Research|January 1, 1989
Effects of a specific beta 2-receptor blocker in neuroleptic-induced akathisiaL Adler, E Duncan, B Angrist, et al.
Neurobiology of Aging|January 1, 1984
CSF somatostatin in Alzheimer's diseaseM Serby, S B Richardson, S Twente, et al.
Psychopharmacology|December 21, 1976
Dopamine receptor alteration in schizophrenia: neuroendocrine evidenceJ Rotrosen, B M Angrist, S Gershon, et al.
Psychopharmacology Bulletin|January 1, 1989
Akathisia: selective beta-blockers and rating instrumentsL A Adler, E Duncan, A Kim, et al.
Pageof 13